Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Qaialdo 10 mg/ml oral suspension EU/1/23/1731/001 |
Spironolactone | Lipomed GmbH | — |
| Qalsody 100 mg solution for injection EU/1/23/1783/001 |
Tofersen | Biogen Netherlands B.V. | — |
| Qarziba 4.5 mg/mL concentrate for solution for infusion EU/1/17/1191/001 |
Dinutuximab beta | EUSA Pharma (Netherlands) B.V. | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/001 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/002 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/003 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/004 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| QINLOCK 50 mg tablets EU/1/21/1569/001-002 |
Ripretinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
| Qlaira film-coated tablets PA1410/058/001 |
Estradiol valerate, Estradiol valerate, Dienogest, Dienogest, Estradiol valerate | Bayer Limited | Marketed |
| Qoyvolma 130 mg concentrate for solution for infusion EU/1/25/1925/003 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qoyvolma 45 mg solution for injection in pre-filled syringe EU/1/25/1925/001 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qoyvolma 90 mg solution for injection in pre-filled syringe EU/1/25/1925/002 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qsiva 11.25 mg/69 mg hard modified-release capsules PA25222/001/003 |
Phentermine hydrochloride, Topiramate | Vivus B.V. | Not marketed |
| Qsiva 15 mg/92 mg hard modified-release capsules PA25222/001/004 |
Phentermine hydrochloride, Topiramate | Vivus B.V. | Not marketed |
| Qsiva 3.75 mg/23 mg hard modified-release capsules PA25222/001/001 |
Phentermine hydrochloride, Topiramate | Vivus B.V. | Not marketed |
| Qsiva 7.5 mg/46 mg hard modified-release capsules PA25222/001/002 |
Phentermine hydrochloride, Topiramate | Vivus B.V. | Not marketed |
| Qtern 5 mg/10 mg film-coated tablets EU/1/16/1108/001-004 |
Dapagliflozin, Saxagliptin | AstraZeneca AB | — |
| Quadramet 1.3 GBq/mL solution for injection. EU/1/97/057/001 |
CIS bio International | — | |
| Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) PA23458/010/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Sanofi Winthrop Industrie | Not marketed |
| Quentiax SR 150mg prolonged-release tablets PA1347/045/001 |
Quetiapine hemifumarate | KRKA, d.d., Novo mesto | Marketed |
| Quentiax SR 200 mg prolonged-release tablets PA1347/045/002 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Quentiax SR 300 mg prolonged-release tablets PA1347/045/003 |
Quetiapine hemifumarate | KRKA, d.d., Novo mesto | Marketed |
| Quentiax SR 400 mg prolonged-release tablets PA1347/045/005 |
Quetiapine hemifumarate | KRKA, d.d., Novo mesto | Marketed |
| Quentiax SR 50 mg prolonged-release tablets PA1347/045/004 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Questran 4g/sachet, Powder for oral suspension PA2239/005/001 |
Colestyramine | CHEPLAPHARM Arzneimittel GmbH | Marketed |
| Quetex 100 mg film-coated tablets PA0711/156/003 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex 200 mg film-coated tablets PA0711/156/004 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex 25mg film-Coated tablets PA0711/156/001 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex 300 mg film-coated tablets PA0711/156/005 |
Quetiapine | Rowex Ltd | Marketed |
| Quetex XR 200 mg prolonged-release tablets PA0711/258/002 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex XR 300 mg prolonged-release tablets PA0711/258/003 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex XR 400 mg prolonged-release tablets PA0711/258/004 |
Quetiapine | Rowex Limited, | Marketed |
| Quetex XR 50 mg prolonged-release tablets PA0711/258/001 |
Quetiapine | Rowex Limited, | Marketed |
| Quetiapine 100 mg film-coated tablets PA2315/117/002 |
Quetiapine | Accord Healthcare Ireland Ltd. | Marketed |
| Quetiapine 200 mg film-coated tablets PA2315/117/003 |
Quetiapine | Accord Healthcare Ireland Ltd. | Not marketed |
| Quetiapine 25 mg film-coated tablets PA2315/117/001 |
Quetiapine | Accord Healthcare Ireland Ltd. | Marketed |
| Quetiapine 300 mg film-coated tablets PA2315/117/004 |
Quetiapine | Accord Healthcare Ireland Ltd. | Not marketed |
| Quetiapine Krka 100mg Film-coated Tablets PA1347/027/002 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Quetiapine Krka 200mg Film-coated Tablets PA1347/027/003 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Quetiapine Krka 25mg Film-coated Tablets PA1347/027/001 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Quetiapine Krka 300mg Film-coated Tablets PA1347/027/004 |
Quetiapine | KRKA, d.d., Novo mesto | Marketed |
| Quinine Sulphate 300 mg film coated tablets PA1986/052/001 |
Quinine sulfate | Teva B.V. | Marketed |
| Quinoderm 10% w/w + 0.5% w/w Cream PA25405/001/001 |
Benzoyl peroxide hydrous, Potassium Hydroxyquinoline Sulphate | UMIP Limited | Not marketed |
| Quinoderm 5% w/w + 0.5% w/w Cream PA25405/001/002 |
Benzoyl peroxide hydrous, Potassium Hydroxyquinoline Sulphate | UMIP Limited | Not marketed |
| Quinsair 240mg Nebuliser solution EU/1/14/973/001 |
Levofloxacin | Chiesi Farmaceutici S.p.A. | — |
| Quofenix 300 mg powder for concentrate for solution for infusion EU/1/19/1393/001 |
DELAFLOXACIN MEGLUMINE | A. Menarini Industrie Farmaceutische Riunite S.r.l. | — |
| Quofenix 450 mg tablets EU/1/19/1393/002-007 |
DELAFLOXACIN MEGLUMINE | A. Menarini Industrie Farmaceutische Riunite S.r.l. | — |
| Qutenza 179 mg cutaneous patch EU/1/09/524/001-002 |
Capsaicin | Grünenthal GmbH | — |
| QUVIVIQ 25 mg film-coated tablets EU/1/22/1638/001-002 |
Daridorexant hydrochloride | Idorsia Pharmaceuticals Deutschland GmbH | — |
| QUVIVIQ 50 mg film-coated tablets EU/1/22/1638/003-004 |
Daridorexant hydrochloride | Idorsia Pharmaceuticals Deutschland GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.